成(cheng)都(dou)海博為(wei)藥業(ye)(ye)(ye)有限公(gong)司(簡稱“海博為(wei)藥業(ye)(ye)(ye)”)成(cheng)立于2019年1月,是一家專注于創新(xin)藥研(yan)(yan)(yan)(yan)(yan)(yan)發(fa)(fa)(fa)(fa)的生物醫藥企業(ye)(ye)(ye)。公(gong)司緊跟(gen)全球醫藥行(xing)業(ye)(ye)(ye)發(fa)(fa)(fa)(fa)展趨勢,瞄準市場上(shang)未被(bei)滿足的臨(lin)床需求(qiu),以創新(xin)為(wei)核心驅(qu)動(dong)力(li)(li)(li),傾力(li)(li)(li)打(da)造小分子創新(xin)藥研(yan)(yan)(yan)(yan)(yan)(yan)發(fa)(fa)(fa)(fa)平臺,同(tong)時輔(fu)以高技術壁壘改(gai)良制(zhi)劑研(yan)(yan)(yan)(yan)(yan)(yan)發(fa)(fa)(fa)(fa)、高端原(yuan)料藥研(yan)(yan)(yan)(yan)(yan)(yan)發(fa)(fa)(fa)(fa)、高附(fu)加值精細化工品研(yan)(yan)(yan)(yan)(yan)(yan)發(fa)(fa)(fa)(fa)。海博為(wei)藥業(ye)(ye)(ye)自成(cheng)立以來,發(fa)(fa)(fa)(fa)展迅速,成(cheng)果(guo)顯(xian)著(zhu)。海博為(wei)藥業(ye)(ye)(ye)現有研(yan)(yan)(yan)(yan)(yan)(yan)發(fa)(fa)(fa)(fa)辦公(gong)場地2000余平方(fang)米,擁(yong)有近百名正式員工,其中博士9人(ren),碩士36人(ren),研(yan)(yan)(yan)(yan)(yan)(yan)發(fa)(fa)(fa)(fa)人(ren)員占比85%以上(shang),研(yan)(yan)(yan)(yan)(yan)(yan)發(fa)(fa)(fa)(fa)實力(li)(li)(li)雄厚。公(gong)司斥資近千萬,先后購(gou)入安裝各種先進精密試驗儀器,有效保證(zheng)各個研(yan)(yan)(yan)(yan)(yan)(yan)發(fa)(fa)(fa)(fa)項(xiang)目(mu)的順(shun)利推進。
海(hai)博(bo)為(wei)藥(yao)業重視團隊建設(she),不(bu)斷打造富有(you)(you)活力(li)、進取的研(yan)發(fa)(fa)氛圍,不(bu)斷完善(shan)人才(cai)(cai)發(fa)(fa)展(zhan)戰略和人才(cai)(cai)激勵(li)機制,持續引進具(ju)有(you)(you)國際先(xian)進水平的高素質人才(cai)(cai),進一步夯實(shi)公司(si)的研(yan)發(fa)(fa)實(shi)力(li)。在未來(lai),海(hai)博(bo)為(wei)藥(yao)業將始終秉承“海(hai)納百川、博(bo)采眾長、良(liang)(liang)藥(yao)濟(ji)民、大(da)有(you)(you)作為(wei)”的企業理(li)念(nian),以“創良(liang)(liang)藥(yao)、中國造”為(wei)使命,不(bu)忘初心,堅持奮斗(dou),努力(li)研(yan)發(fa)(fa)出造福(fu)廣大(da)患者(zhe)的良(liang)(liang)心好藥(yao),譜寫中國醫藥(yao)發(fa)(fa)展(zhan)新篇章(zhang)!